VistaGen Therapeutics Mutual Funds

Health Care & Life Sciences » Biotechnology | VistaGen Therapeutics Inc.

VistaGen Therapeutics Inc. | Mutual Funds

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Vanguard Extended Market Index Fund

191,775

0.74%

11,400

07/31/2018

Fidelity Spartan Extended Market Index Fund

114,368

0.44%

07/31/2018

Fidelity Spartan Total Market Index Fund

22,368

0.09%

07/31/2018

View Profile

Address	343 Allerton Avenue South San Francisco California 94080 United States
Employees	-
Website	http://www.vistagen.com
Updated	07/08/2019
VistaGen Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of new generation medicines for depression and other diseases and disorders of the central nervous system. It focuses on AV-101 product, an oral, non-opioid and non-sedating therapy that offers the potential to be a new at-home treatment for multiple central nervous system indications with high-unmet medical need. The company was founded by H.